314 related articles for article (PubMed ID: 25605438)
1. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
Peles E; Schreiber S; Linzy S; Domani Y; Adelson M
J Subst Abuse Treat; 2015 Jul; 54():44-9. PubMed ID: 25605438
[TBL] [Abstract][Full Text] [Related]
2. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal.
Peles E; Schreiber S; Linzy S; Adelson M
Am J Orthopsychiatry; 2010 Jul; 80(3):311-6. PubMed ID: 20636936
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome.
Peles E; Adelson M; Schreiber S
Isr J Psychiatry Relat Sci; 2014; 51(4):285-8. PubMed ID: 25841226
[TBL] [Abstract][Full Text] [Related]
4. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
5. Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization.
Adelson M; Smith D; Peles E
J Addict Dis; 2021; 39(2):226-233. PubMed ID: 33559536
[TBL] [Abstract][Full Text] [Related]
6. One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel.
Peles E; Linzy S; Kreek M; Adelson M
J Addict Dis; 2008; 27(4):11-25. PubMed ID: 19042587
[TBL] [Abstract][Full Text] [Related]
7. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
[TBL] [Abstract][Full Text] [Related]
8. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E; Schreiber S; Rados V; Adelson M
J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
Bleich A; Gelkopf M; Weizman T; Adelson M
Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas.
Adelson M; Linzy S; Peles E
Subst Use Misuse; 2018 Jan; 53(2):230-238. PubMed ID: 28574738
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors.
Sason A; Adelson M; Schreiber S; Peles E
Drug Alcohol Depend; 2018 Aug; 189():8-11. PubMed ID: 29857329
[TBL] [Abstract][Full Text] [Related]
12. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
13. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.
Peles E; Schreiber S; Domany Y; Adelson M
World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT).
Peles E; Schreiber S; Adelson M
Eur Neuropsychopharmacol; 2008 Mar; 18(3):188-93. PubMed ID: 17997285
[TBL] [Abstract][Full Text] [Related]
15. Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment.
Peles E; Schreiber S; Sutzman A; Adelson M
Psychopathology; 2012; 45(5):327-33. PubMed ID: 22796643
[TBL] [Abstract][Full Text] [Related]
16. Is Internet Addiction Prevalent Among Methadone Maintenance Treatment Patients? Data from Las Vegas and Tel Aviv.
Peles E; Linzy S; Sason A; Tene O; Adelson M
J Addict Dis; 2015; 34(4):296-302. PubMed ID: 26284288
[TBL] [Abstract][Full Text] [Related]
17. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients.
Schreiber S; Peles E; Adelson M
Drug Alcohol Depend; 2008 Jan; 92(1-3):79-85. PubMed ID: 17706374
[TBL] [Abstract][Full Text] [Related]
18. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
19. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
20. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.
Weizman T; Gelkopf M; Melamed Y; Adelson M; Bleich A
Aust N Z J Psychiatry; 2004; 38(1-2):42-6. PubMed ID: 14731193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
